Harvard Bioscience (FRA:HBI) Sale Of Investment : €0.46 Mil (TTM As of Mar. 2024)

View and export this data going back to . Start your Free Trial

What is Harvard Bioscience Sale Of Investment?

Harvard Bioscience's sale of investment for the three months ended in Mar. 2024 was €0.46 Mil. It means Harvard Bioscience gained €0.46 Mil from selling investments. Harvard Bioscience's sale of investment for the trailing twelve months (TTM) ended in Mar. 2024 was €0.46 Mil.

Compared with last quarter (€0.00 Mil in Dec. 2023 ), Harvard Bioscience gained more money from selling investments in Mar. 2024 (€0.46 Mil).

Harvard Bioscience Sale Of Investment Historical Data

The historical data trend for Harvard Bioscience's Sale Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Harvard Bioscience Sale Of Investment Chart

Harvard Bioscience Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Sale Of Investment

Get a 7-Day Free Trial

Harvard Bioscience Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Sale Of Investment	Get a 7-Day Free Trial															-	-	-	-	0.46

Harvard Bioscience Sale Of Investment Calculation

Sale of Investments represents cash inflow on the sale of investments in securities.

Sale Of Investment for the trailing twelve months (TTM) ended in Mar. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €0.46 Mil.

Harvard Bioscience Sale Of Investment Related Terms

Thank you for viewing the detailed overview of Harvard Bioscience's Sale Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Harvard Bioscience (FRA:HBI) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Harvard Bioscience Inc (FRA:HBI) » Definitions » Sale Of Investment

Comparable Companies

Traded in Other Exchanges

HBIO:USA HBI:Germany

Address

84 October Hill Road, Holliston, MA, USA, 01746

Website

https://www.harvardbioscience.com

Harvard Bioscience Inc is a developer, manufacturer, and seller of technologies, specialized products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. Its primary focus is scientific instruments used to advance life science and research. With operations in North America, Europe and china it sells through a combination of direct and distribution channels to customers around the world. The product brands of the company include Harvard Apparatus, DSI, Buxco, Biochrom, BTX, Heka, Hugo Sachs, Multichannel Systems MCS GmbH, and Panlab.. The majority of its revenue comes from the United States.